Oragenics Inc (OGEN) Stock Sees a-10.20 Decrease

The stock of Oragenics Inc (OGEN) has seen a -6.38% decrease in the past week, with a -9.59% drop in the past month, and a -80.53% decrease in the past quarter. The volatility ratio for the week is 7.37%, and the volatility levels for the past 30 days are at 6.29% for OGEN. The simple moving average for the past 20 days is -8.05% for OGEN’s stock, with a -62.12% simple moving average for the past 200 days.

Is It Worth Investing in Oragenics Inc (AMEX: OGEN) Right Now?

Additionally, the 36-month beta value for OGEN is 0.32. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The public float for OGEN is 3.52M and currently, short sellers hold a 1.66% ratio of that float. The average trading volume of OGEN on April 04, 2024 was 86.86K shares.

OGEN) stock’s latest price update

Oragenics Inc (AMEX: OGEN)’s stock price has dropped by -10.20 in relation to previous closing price of 1.47. Nevertheless, the company has seen a loss of -6.38% in its stock price over the last five trading days. InvestorPlace reported 2024-02-28 that Oragenics (NYSEMKT: OGEN ) stock is falling on Wednesday after the antibiotics development company announced details of a public offering for its shares. Oragenics is selling 1.4 million shares of OGEN stock for $1.50 each.

OGEN Trading at -47.89% from the 50-Day Moving Average

After a stumble in the market that brought OGEN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -82.95% of loss for the given period.

Volatility was left at 6.29%, however, over the last 30 days, the volatility rate increased by 7.37%, as shares sank -8.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -73.28% lower at present.

During the last 5 trading sessions, OGEN fell by -6.38%, which changed the moving average for the period of 200-days by -56.00% in comparison to the 20-day moving average, which settled at $1.4295. In addition, Oragenics Inc saw -76.54% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at OGEN starting from Telling Fred, who sale 3,500 shares at the price of $3.57 back on Nov 30 ’23. After this action, Telling Fred now owns 38,345 shares of Oragenics Inc, valued at $12,488 using the latest closing price.

Stock Fundamentals for OGEN

Current profitability levels for the company are sitting at:

  • -282.35 for the present operating margin
  • 0.27 for the gross margin

The net margin for Oragenics Inc stands at -547.08. The total capital return value is set at -3.36. Equity return is now at value -255.36, with -209.44 for asset returns.

Based on Oragenics Inc (OGEN), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -22.61. The debt to equity ratio resting at 0.1. The interest coverage ratio of the stock is -347.53.

Currently, EBITDA for the company is -10.64 million with net debt to EBITDA at 0.3. When we switch over and look at the enterprise to sales, we see a ratio of 73.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.15.

Conclusion

In conclusion, Oragenics Inc (OGEN) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts